| 1 | diabetic | 14,345 |
| 2 | cirrhotic | 605 |
| 3 | chagasic | 73 |
| 4 | fructose-fed | 43 |
| 5 | hfd-fed | 34 |
| 6 | non-transplant | 19 |
| 7 | scoliotic | 17 |
| 8 | amyloidotic | 15 |
| 9 | nonstroke | 14 |
| 10 | bortezomib-induced | 13 |
| 11 | 'diabetic | 11 |
| 12 | romiplostim-treated | 10 |
| 13 | dipstick-positive | 8 |
| 14 | 2589 | 7 |
| 15 | 3337 | 7 |
| 16 | des-treated | 7 |
| 17 | ex16 | 7 |
| 18 | naproxen-treated | 7 |
| 19 | troglitazone-treated | 7 |
| 20 | 3507 | 6 |
| 21 | esmolol-treated | 6 |
| 22 | mdma-treated | 6 |
| 23 | amyloid-positive | 5 |
| 24 | srl-treated | 5 |
| 25 | tgab-positive | 5 |
| 26 | 2,043 | 4 |
| 27 | 2989 | 4 |
| 28 | 3416 | 4 |
| 29 | allogeneic-hct | 4 |
| 30 | caspofungin-treated | 4 |
| 31 | diabetic-hypercholesterolemic | 4 |
| 32 | low-mobile | 4 |
| 33 | nsaids-induced | 4 |
| 34 | oxaliplatin-treated | 4 |
| 35 | sumatriptan-treated | 4 |
| 36 | 2,145 | 3 |
| 37 | 20,451 | 3 |
| 38 | 4960 | 3 |
| 39 | 5799 | 3 |
| 40 | 6558 | 3 |
| 41 | adalimumab-randomised | 3 |
| 42 | afatinib-treated | 3 |
| 43 | carrageenan-treated | 3 |
| 44 | cat-allergic | 3 |
| 45 | emergency-related | 3 |
| 46 | fidaxomicin-treated | 3 |
| 47 | heat-affected | 3 |
| 48 | itraconazole-treated | 3 |
| 49 | ket-induced | 3 |
| 50 | long-surviving | 3 |
| 51 | mg-depleted | 3 |
| 52 | non-entered | 3 |
| 53 | nonburn | 3 |
| 54 | ptps-deficient | 3 |
| 55 | thrombolysis-eligible | 3 |
| 56 | tpm-treated | 3 |
| 57 | 11,945 | 2 |
| 58 | 17,420 | 2 |
| 59 | 19,756 | 2 |
| 60 | 22,063 | 2 |
| 61 | 3,095 | 2 |
| 62 | 3,672 | 2 |
| 63 | 3,782 | 2 |
| 64 | 3,991 | 2 |
| 65 | 32,258 | 2 |
| 66 | 3997 | 2 |
| 67 | 4,155 | 2 |
| 68 | 4,763 | 2 |
| 69 | 46,991 | 2 |
| 70 | 4617 | 2 |
| 71 | 5814 | 2 |
| 72 | 6876 | 2 |
| 73 | 69,958 | 2 |
| 74 | 7/58 | 2 |
| 75 | 7576 | 2 |
| 76 | 8504 | 2 |
| 77 | 8653 | 2 |
| 78 | 8940 | 2 |
| 79 | aztreonam-treated | 2 |
| 80 | bacteria-negative | 2 |
| 81 | cefprozil-treated | 2 |
| 82 | chronically-infected | 2 |
| 83 | darbepoetin-treated | 2 |
| 84 | fibrocaps-treated | 2 |
| 85 | helicobacter-infected | 2 |
| 86 | hlcat+/ldlr-/- | 2 |
| 87 | hmpl-004-treated | 2 |
| 88 | infliximab-to-abatacept | 2 |
| 89 | inoperable/high-risk | 2 |
| 90 | insulin-eligible | 2 |
| 91 | life-diabetic | 2 |
| 92 | low-impulsive | 2 |
| 93 | lupic | 2 |
| 94 | myrrh-treated | 2 |
| 95 | nitroprusside-treated | 2 |
| 96 | non-immunocompromized | 2 |
| 97 | op-poisoned | 2 |
| 98 | pcr-diagnosed | 2 |
| 99 | pheochromocytoma-induced | 2 |
| 100 | rilonacept-treated | 2 |
| 101 | savr-treated | 2 |
| 102 | sca3-associated | 2 |
| 103 | simeprevir/pr-treated | 2 |
| 104 | sipuleucel-t-treated | 2 |
| 105 | smv-treated | 2 |
| 106 | solvd-eligible | 2 |
| 107 | sulconazole-treated | 2 |
| 108 | ultrasonographic-guided | 2 |
| 109 | vascular-complicated | 2 |
| 110 | vigabatrin-exposed | 2 |
| 111 | 'uremic | 1 |
| 112 | -ischemic | 1 |
| 113 | 0.85:67 | 1 |
| 114 | 1,174,545 | 1 |
| 115 | 1,732 | 1 |
| 116 | 1,880 | 1 |
| 117 | 1,952 | 1 |
| 118 | 10,047 | 1 |
| 119 | 10,082 | 1 |
| 120 | 10,129 | 1 |
| 121 | 10,217 | 1 |
| 122 | 10,222 | 1 |
| 123 | 10,230 | 1 |
| 124 | 10,280 | 1 |
| 125 | 10,282 | 1 |
| 126 | 10,364 | 1 |
| 127 | 10,469 | 1 |
| 128 | 10,625 | 1 |
| 129 | 10,660 | 1 |
| 130 | 10,711 | 1 |
| 131 | 10,727 | 1 |
| 132 | 10,735 | 1 |
| 133 | 10,771 | 1 |
| 134 | 10,798,343 | 1 |
| 135 | 10,805 | 1 |
| 136 | 10,819 | 1 |
| 137 | 10,972 | 1 |
| 138 | 101,801 | 1 |
| 139 | 102,060 | 1 |
| 140 | 102,647 | 1 |
| 141 | 103,972 | 1 |
| 142 | 10326 | 1 |
| 143 | 104,306 | 1 |
| 144 | 109,002 | 1 |
| 145 | 109,836 | 1 |
| 146 | 11,108 | 1 |
| 147 | 11,143 | 1 |
| 148 | 11,215 | 1 |
| 149 | 11,216 | 1 |
| 150 | 11,321 | 1 |
| 151 | 11,369 | 1 |
| 152 | 11,377 | 1 |
| 153 | 11,638 | 1 |
| 154 | 111,818 | 1 |
| 155 | 11141 | 1 |
| 156 | 113,394 | 1 |
| 157 | 115,608 | 1 |
| 158 | 12,072 | 1 |
| 159 | 12,168 | 1 |
| 160 | 12,184 | 1 |
| 161 | 12,236 | 1 |
| 162 | 12,358 | 1 |
| 163 | 12,505 | 1 |
| 164 | 12,585 | 1 |
| 165 | 12,812 | 1 |
| 166 | 121,910 | 1 |
| 167 | 122,458 | 1 |
| 168 | 124,734 | 1 |
| 169 | 125,161 | 1 |
| 170 | 13,169 | 1 |
| 171 | 13,255 | 1 |
| 172 | 13,295 | 1 |
| 173 | 13,320 | 1 |
| 174 | 13,412 | 1 |
| 175 | 13,691 | 1 |
| 176 | 13,699 | 1 |
| 177 | 13,762 | 1 |
| 178 | 13,776 | 1 |
| 179 | 13,812 | 1 |
| 180 | 13,825 | 1 |
| 181 | 13,955 | 1 |
| 182 | 13269 | 1 |
| 183 | 132:66:66 | 1 |
| 184 | 13415 | 1 |
| 185 | 135,871 | 1 |
| 186 | 136/1304 | 1 |
| 187 | 137,277 | 1 |
| 188 | 14,151 | 1 |
| 189 | 14,252 | 1 |
| 190 | 14,277 | 1 |
| 191 | 14,326 | 1 |
| 192 | 14,644 | 1 |
| 193 | 14,683 | 1 |
| 194 | 14,830 | 1 |
| 195 | 14,933 | 1 |
| 196 | 14,935 | 1 |
| 197 | 14.344 | 1 |
| 198 | 142,158 | 1 |
| 199 | 15,711 | 1 |
| 200 | 15,762 | 1 |
| 201 | 152,729 | 1 |
| 202 | 155,243 | 1 |
| 203 | 156,798 | 1 |
| 204 | 156/385 | 1 |
| 205 | 16,011 | 1 |
| 206 | 16,173 | 1 |
| 207 | 16,192 | 1 |
| 208 | 16,411 | 1 |
| 209 | 16,451 | 1 |
| 210 | 16,489 | 1 |
| 211 | 16,812 | 1 |
| 212 | 16,872 | 1 |
| 213 | 16,912 | 1 |
| 214 | 16-24-year-old | 1 |
| 215 | 16-to-78-year-old | 1 |
| 216 | 161,585 | 1 |
| 217 | 163,668 | 1 |
| 218 | 164,497 | 1 |
| 219 | 167,311 | 1 |
| 220 | 167,839 | 1 |
| 221 | 167,907 | 1 |
| 222 | 169,518 | 1 |
| 223 | 17,002 | 1 |
| 224 | 17,028 | 1 |
| 225 | 17,137 | 1 |
| 226 | 17,413 | 1 |
| 227 | 17,475 | 1 |
| 228 | 17,570 | 1 |
| 229 | 17,776 | 1 |
| 230 | 17,888 | 1 |
| 231 | 17,990 | 1 |
| 232 | 17-18-year-old | 1 |
| 233 | 17029 | 1 |
| 234 | 171,885 | 1 |
| 235 | 171/309 | 1 |
| 236 | 17157 | 1 |
| 237 | 173,028 | 1 |
| 238 | 179,122 | 1 |
| 239 | 18,061 | 1 |
| 240 | 18,064 | 1 |
| 241 | 18,206 | 1 |
| 242 | 18,260 | 1 |
| 243 | 18,334 | 1 |
| 244 | 18,867 | 1 |
| 245 | 181,993 | 1 |
| 246 | 181/1000 | 1 |
| 247 | 184,480 | 1 |
| 248 | 186,663 | 1 |
| 249 | 19,013 | 1 |
| 250 | 19,735 | 1 |
| 251 | 19,826 | 1 |
| 252 | 19,867 | 1 |
| 253 | 19,942 | 1 |
| 254 | 190,664 | 1 |
| 255 | 19842 | 1 |
| 256 | 198mb | 1 |
| 257 | 2,225 | 1 |
| 258 | 2,383 | 1 |
| 259 | 2,487 | 1 |
| 260 | 2,568 | 1 |
| 261 | 2,599,685 | 1 |
| 262 | 2,633 | 1 |
| 263 | 2,660,929 | 1 |
| 264 | 2,698 | 1 |
| 265 | 2,803 | 1 |
| 266 | 2,821 | 1 |
| 267 | 2,911 | 1 |
| 268 | 20,170 | 1 |
| 269 | 20,478 | 1 |
| 270 | 20,479 | 1 |
| 271 | 20,599 | 1 |
| 272 | 20,750 | 1 |
| 273 | 20481 | 1 |
| 274 | 206,940 | 1 |
| 275 | 20618 | 1 |
| 276 | 21,062 | 1 |
| 277 | 21,379 | 1 |
| 278 | 21,533 | 1 |
| 279 | 21,946 | 1 |
| 280 | 21,972 | 1 |
| 281 | 218,043 | 1 |
| 282 | 22,052 | 1 |
| 283 | 22,094 | 1 |
| 284 | 22,274 | 1 |
| 285 | 22,275 | 1 |
| 286 | 22,525 | 1 |
| 287 | 22.239 | 1 |
| 288 | 221,799 | 1 |
| 289 | 22282 | 1 |
| 290 | 223,313 | 1 |
| 291 | 226,709 | 1 |
| 292 | 229,116 | 1 |
| 293 | 23,357 | 1 |
| 294 | 23,600 | 1 |
| 295 | 23,668 | 1 |
| 296 | 23,931 | 1 |
| 297 | 235,290 | 1 |
| 298 | 24,196 | 1 |
| 299 | 24,214 | 1 |
| 300 | 24,322 | 1 |
| 301 | 24,644 | 1 |
| 302 | 24,910 | 1 |
| 303 | 24,979 | 1 |
| 304 | 24.2/100 | 1 |
| 305 | 24.623 | 1 |
| 306 | 240,268 | 1 |
| 307 | 242,738 | 1 |
| 308 | 242/280 | 1 |
| 309 | 25,280 | 1 |
| 310 | 25,425 | 1 |
| 311 | 25,486 | 1 |
| 312 | 25,584 | 1 |
| 313 | 25,643 | 1 |
| 314 | 25340 | 1 |
| 315 | 26,155 | 1 |
| 316 | 26,437 | 1 |
| 317 | 26,451 | 1 |
| 318 | 26,833 | 1 |
| 319 | 26,957 | 1 |
| 320 | 27,023 | 1 |
| 321 | 27,039 | 1 |
| 322 | 27,802 | 1 |
| 323 | 27,807 | 1 |
| 324 | 27,947 | 1 |
| 325 | 28,144 | 1 |
| 326 | 28,150 | 1 |
| 327 | 28,628 | 1 |
| 328 | 28,991 | 1 |
| 329 | 29,488 | 1 |
| 330 | 29,827 | 1 |
| 331 | 29,954 | 1 |
| 332 | 290,847 | 1 |
| 333 | 298/362 | 1 |
| 334 | 3,075 | 1 |
| 335 | 3,104 | 1 |
| 336 | 3,121 | 1 |
| 337 | 3,171 | 1 |
| 338 | 3,181 | 1 |
| 339 | 3,286 | 1 |
| 340 | 3,373 | 1 |
| 341 | 3,508 | 1 |
| 342 | 3,570 | 1 |
| 343 | 3,641 | 1 |
| 344 | 3,678,868 | 1 |
| 345 | 3,724 | 1 |
| 346 | 3,737 | 1 |
| 347 | 3,798 | 1 |
| 348 | 3,904 | 1 |
| 349 | 3.600 | 1 |
| 350 | 30,076 | 1 |
| 351 | 30,139 | 1 |
| 352 | 30,348 | 1 |
| 353 | 30,561 | 1 |
| 354 | 31,020 | 1 |
| 355 | 32,025 | 1 |
| 356 | 32,707 | 1 |
| 357 | 32,795 | 1 |
| 358 | 32,919 | 1 |
| 359 | 33,238 | 1 |
| 360 | 33,356 | 1 |
| 361 | 33,429 | 1 |
| 362 | 33,669 | 1 |
| 363 | 338,191 | 1 |
| 364 | 33885 | 1 |
| 365 | 34,122 | 1 |
| 366 | 34,533 | 1 |
| 367 | 35,239 | 1 |
| 368 | 350,031 | 1 |
| 369 | 36,489 | 1 |
| 370 | 36,869 | 1 |
| 371 | 37,010 | 1 |
| 372 | 37,229 | 1 |
| 373 | 37,515 | 1 |
| 374 | 37,695 | 1 |
| 375 | 374,068 | 1 |
| 376 | 38,072 | 1 |
| 377 | 38,385 | 1 |
| 378 | 38,439 | 1 |
| 379 | 39030 | 1 |
| 380 | 3905 | 1 |
| 381 | 4,006 | 1 |
| 382 | 4,165 | 1 |
| 383 | 4,225 | 1 |
| 384 | 4,302 | 1 |
| 385 | 4,459 | 1 |
| 386 | 4,498 | 1 |
| 387 | 4,609 | 1 |
| 388 | 4,814 | 1 |
| 389 | 4,872 | 1 |
| 390 | 40,028 | 1 |
| 391 | 40,907 | 1 |
| 392 | 4048 | 1 |
| 393 | 408/1000 | 1 |
| 394 | 41,088 | 1 |
| 395 | 41,479 | 1 |
| 396 | 41,976 | 1 |
| 397 | 415,409 | 1 |
| 398 | 42,016 | 1 |
| 399 | 43,305 | 1 |
| 400 | 43,410 | 1 |
| 401 | 43,625 | 1 |
| 402 | 43,904 | 1 |
| 403 | 44,012 | 1 |
| 404 | 44,948 | 1 |
| 405 | 45,247 | 1 |
| 406 | 451/15,203 | 1 |
| 407 | 4649 | 1 |
| 408 | 47,148 | 1 |
| 409 | 48,599 | 1 |
| 410 | 48,950 | 1 |
| 411 | 480,942 | 1 |
| 412 | 48248 | 1 |
| 413 | 4859 | 1 |
| 414 | 49,275 | 1 |
| 415 | 49,599 | 1 |
| 416 | 49,697 | 1 |
| 417 | 490,000 | 1 |
| 418 | 499,593 | 1 |
| 419 | 4998 | 1 |
| 420 | 5,118 | 1 |
| 421 | 5,207 | 1 |
| 422 | 5,239 | 1 |
| 423 | 5,332 | 1 |
| 424 | 5,477 | 1 |
| 425 | 5,491 | 1 |
| 426 | 5,526 | 1 |
| 427 | 5,587 | 1 |
| 428 | 5,592 | 1 |
| 429 | 5,716 | 1 |
| 430 | 5,792 | 1 |
| 431 | 5,833 | 1 |
| 432 | 5,889 | 1 |
| 433 | 50,025 | 1 |
| 434 | 50,242 | 1 |
| 435 | 5078 | 1 |
| 436 | 51,303 | 1 |
| 437 | 51/80 | 1 |
| 438 | 51895 | 1 |
| 439 | 52,010 | 1 |
| 440 | 52,647 | 1 |
| 441 | 52,778 | 1 |
| 442 | 5295 | 1 |
| 443 | 54,453 | 1 |
| 444 | 54174 | 1 |
| 445 | 5458 | 1 |
| 446 | 5492 | 1 |
| 447 | 5590 | 1 |
| 448 | 56,031 | 1 |
| 449 | 56,561 | 1 |
| 450 | 565,016 | 1 |
| 451 | 5652 | 1 |
| 452 | 5659 | 1 |
| 453 | 57,246 | 1 |
| 454 | 57,491 | 1 |
| 455 | 5720 | 1 |
| 456 | 5737 | 1 |
| 457 | 5754 | 1 |
| 458 | 579,521 | 1 |
| 459 | 58,009 | 1 |
| 460 | 5802 | 1 |
| 461 | 584,784 | 1 |
| 462 | 5856 | 1 |
| 463 | 5877 | 1 |
| 464 | 5880 | 1 |
| 465 | 5899 | 1 |
| 466 | 59,004 | 1 |
| 467 | 59,233 | 1 |
| 468 | 599,141 | 1 |
| 469 | 6,065 | 1 |
| 470 | 6,105 | 1 |
| 471 | 6,162 | 1 |
| 472 | 6,191 | 1 |
| 473 | 6,196 | 1 |
| 474 | 6,236 | 1 |
| 475 | 6,271 | 1 |
| 476 | 6,336 | 1 |
| 477 | 6,346 | 1 |
| 478 | 6,367 | 1 |
| 479 | 6,377 | 1 |
| 480 | 6,430 | 1 |
| 481 | 6,483 | 1 |
| 482 | 6,496 | 1 |
| 483 | 6,514 | 1 |
| 484 | 6,524 | 1 |
| 485 | 6,563 | 1 |
| 486 | 6,750 | 1 |
| 487 | 6,776 | 1 |
| 488 | 6,778 | 1 |
| 489 | 6,910 | 1 |
| 490 | 60,386 | 1 |
| 491 | 600/1,094 | 1 |
| 492 | 602,222 | 1 |
| 493 | 6152 | 1 |
| 494 | 6158 | 1 |
| 495 | 6194 | 1 |
| 496 | 623,358 | 1 |
| 497 | 6289 | 1 |
| 498 | 6345 | 1 |
| 499 | 6363 | 1 |
| 500 | 64,387 | 1 |
| 501 | 6401 | 1 |
| 502 | 6409 | 1 |
| 503 | 6516 | 1 |
| 504 | 6549 | 1 |
| 505 | 67,851 | 1 |
| 506 | 6738 | 1 |
| 507 | 6774 | 1 |
| 508 | 68,236 | 1 |
| 509 | 681,122 | 1 |
| 510 | 6810 | 1 |
| 511 | 682,993 | 1 |
| 512 | 6844 | 1 |
| 513 | 6873 | 1 |
| 514 | 69,060 | 1 |
| 515 | 6905 | 1 |
| 516 | 6942 | 1 |
| 517 | 6963 | 1 |
| 518 | 7,414 | 1 |
| 519 | 7,540 | 1 |
| 520 | 7,619 | 1 |
| 521 | 7,648 | 1 |
| 522 | 7,793 | 1 |
| 523 | 7,974 | 1 |
| 524 | 7,994 | 1 |
| 525 | 70,403 | 1 |
| 526 | 70,500 | 1 |
| 527 | 70,764 | 1 |
| 528 | 7135 | 1 |
| 529 | 7186 | 1 |
| 530 | 72,597 | 1 |
| 531 | 72/173 | 1 |
| 532 | 7226 | 1 |
| 533 | 7240 | 1 |
| 534 | 73,012 | 1 |
| 535 | 7472 | 1 |
| 536 | 7489 | 1 |
| 537 | 7499 | 1 |
| 538 | 75,086 | 1 |
| 539 | 75,873 | 1 |
| 540 | 76,397 | 1 |
| 541 | 7640 | 1 |
| 542 | 77,552 | 1 |
| 543 | 7754 | 1 |
| 544 | 7783 | 1 |
| 545 | 78,230 | 1 |
| 546 | 7924 | 1 |
| 547 | 7956 | 1 |
| 548 | 8,015 | 1 |
| 549 | 8,216 | 1 |
| 550 | 8,252 | 1 |
| 551 | 8,424 | 1 |
| 552 | 8,443 | 1 |
| 553 | 8,515 | 1 |
| 554 | 8,528 | 1 |
| 555 | 8,695 | 1 |
| 556 | 8,708 | 1 |
| 557 | 8,771 | 1 |
| 558 | 8,785 | 1 |
| 559 | 8,909 | 1 |
| 560 | 8,988 | 1 |
| 561 | 8.666 | 1 |
| 562 | 80,290 | 1 |
| 563 | 8004 | 1 |
| 564 | 81,081 | 1 |
| 565 | 81,649 | 1 |
| 566 | 8158 | 1 |
| 567 | 81788 | 1 |
| 568 | 82,018 | 1 |
| 569 | 82,784 | 1 |
| 570 | 8204 | 1 |
| 571 | 83,953 | 1 |
| 572 | 8519 | 1 |
| 573 | 8555 | 1 |
| 574 | 86,598 | 1 |
| 575 | 8682 | 1 |
| 576 | 8718 | 1 |
| 577 | 8880 | 1 |
| 578 | 89,703 | 1 |
| 579 | 8988 | 1 |
| 580 | 8990 | 1 |
| 581 | 9,027 | 1 |
| 582 | 9,080 | 1 |
| 583 | 9,124 | 1 |
| 584 | 9,138 | 1 |
| 585 | 9,187 | 1 |
| 586 | 9,297 | 1 |
| 587 | 9,325 | 1 |
| 588 | 9,393 | 1 |
| 589 | 9,405 | 1 |
| 590 | 9,496 | 1 |
| 591 | 9,513 | 1 |
| 592 | 9,704 | 1 |
| 593 | 90,480 | 1 |
| 594 | 9004 | 1 |
| 595 | 9016 | 1 |
| 596 | 9020 | 1 |
| 597 | 9199 | 1 |
| 598 | 9295 | 1 |
| 599 | 93,451 | 1 |
| 600 | 9388 | 1 |
| 601 | 94,558 | 1 |
| 602 | 94,785 | 1 |
| 603 | 9441 | 1 |
| 604 | 9510 | 1 |
| 605 | 9519 | 1 |
| 606 | 96.022 | 1 |
| 607 | 97,458 | 1 |
| 608 | 9753 | 1 |
| 609 | 9766 | 1 |
| 610 | 98,869 | 1 |
| 611 | 9838 | 1 |
| 612 | 9861 | 1 |
| 613 | 9948 | 1 |
| 614 | a10-treated | 1 |
| 615 | a5-treated | 1 |
| 616 | acalculic | 1 |
| 617 | acne-scarred | 1 |
| 618 | adefovir-treated | 1 |
| 619 | adherent/non-adherent | 1 |
| 620 | adhesion-free | 1 |
| 621 | age-and-sex-matched | 1 |
| 622 | alda-eligible | 1 |
| 623 | almotriptan-treated | 1 |
| 624 | alt-elevating | 1 |
| 625 | ambd-treated | 1 |
| 626 | ami-hospitalized | 1 |
| 627 | antecedes | 1 |
| 628 | arb/acei | 1 |
| 629 | aspirin-allocated | 1 |
| 630 | atnf-naive | 1 |
| 631 | atovaquone-proguanil-treated | 1 |
| 632 | auto-antibody-positive | 1 |
| 633 | avv-tenos-transduced | 1 |
| 634 | biomarker-evaluated | 1 |
| 635 | boceprevir-treated | 1 |
| 636 | c-ses-treated | 1 |
| 637 | ca125-positive | 1 |
| 638 | cabg-eligible | 1 |
| 639 | cabozantinib-treated | 1 |
| 640 | cae-treated | 1 |
| 641 | capcaa-associated | 1 |
| 642 | carboplatin/paclitaxel-induced | 1 |
| 643 | cardiac-stable | 1 |
| 644 | cbz-erc-treated | 1 |
| 645 | cd16+/ido+-expressing | 1 |
| 646 | cfa-negative | 1 |
| 647 | cgrp-immunopositive | 1 |
| 648 | chemotherapy-evoked | 1 |
| 649 | cisca-treated | 1 |
| 650 | cldn16-related | 1 |
| 651 | cnis-treated | 1 |
| 652 | corneoconjunctival | 1 |
| 653 | cryoblation | 1 |
| 654 | ctc/ml | 1 |
| 655 | cysticercotic | 1 |
| 656 | cytokine-expressing | 1 |
| 657 | dacarbazine-treated | 1 |
| 658 | daclatasvir-treated | 1 |
| 659 | darunavir/ritonavir-treated | 1 |
| 660 | dcf-induced | 1 |
| 661 | death/105 | 1 |
| 662 | detemir-treated | 1 |
| 663 | dhea-substituted | 1 |
| 664 | dhp-treated | 1 |
| 665 | di-abetic | 1 |
| 666 | diabetic- | 1 |
| 667 | diphenhydramine-treated | 1 |
| 668 | doctor-referred | 1 |
| 669 | dysmennorheic | 1 |
| 670 | earth-bound | 1 |
| 671 | enoxaparin/vka-treated | 1 |
| 672 | ertapenem-treated | 1 |
| 673 | erythropoietin-naive | 1 |
| 674 | euro-canadian | 1 |
| 675 | ex-smokers/never-smoked | 1 |
| 676 | females/1 | 1 |
| 677 | fibrinolysis-treated | 1 |
| 678 | flat-arched | 1 |
| 679 | fluorouracil-refractory | 1 |
| 680 | fractures.twenty-four | 1 |
| 681 | gada-positive | 1 |
| 682 | gbp-treated | 1 |
| 683 | gde-free | 1 |
| 684 | giop-eligible | 1 |
| 685 | giop-treated | 1 |
| 686 | gonorrhea-infected | 1 |
| 687 | good-mr | 1 |
| 688 | good-ps | 1 |
| 689 | group,12 | 1 |
| 690 | group,15 | 1 |
| 691 | half-blooded | 1 |
| 692 | health.gonococcal | 1 |
| 693 | hec-treated | 1 |
| 694 | hep-treated | 1 |
| 695 | hidac-3-treated | 1 |
| 696 | high-utilization | 1 |
| 697 | hiv-/hcv-coinfected | 1 |
| 698 | hmg-coa-reductase-induced | 1 |
| 699 | hn-allergic | 1 |
| 700 | homokaryotypic | 1 |
| 701 | hospitalized-manic | 1 |
| 702 | htupa-treated | 1 |
| 703 | i150/a10-treated | 1 |
| 704 | i150/a5-treated | 1 |
| 705 | i300-treated | 1 |
| 706 | i300/a5-treated | 1 |
| 707 | ibrutinib-treated | 1 |
| 708 | icu-treated | 1 |
| 709 | ihc+ | 1 |
| 710 | imatinib-naïve | 1 |
| 711 | imipenem/cilastatin-treated | 1 |
| 712 | intetumumab-treated | 1 |
| 713 | invasion-supporting | 1 |
| 714 | ischemic-dilated | 1 |
| 715 | lamivudin-refractory | 1 |
| 716 | latero-frontal | 1 |
| 717 | ldt-treated | 1 |
| 718 | leukapheresed | 1 |
| 719 | lfn-naive | 1 |
| 720 | lopinavir/ritonavir-treated | 1 |
| 721 | lower-priority | 1 |
| 722 | lvd-treated | 1 |
| 723 | m-csf-treated | 1 |
| 724 | maximally-treated | 1 |
| 725 | mericitabine-treated | 1 |
| 726 | merit-hf-eligible | 1 |
| 727 | micafungin-treated | 1 |
| 728 | mustt-enrolled | 1 |
| 729 | mustt/madit-type | 1 |
| 730 | mvac-treated | 1 |
| 731 | n=6259 | 1 |
| 732 | nafld-suspected | 1 |
| 733 | nausea-free | 1 |
| 734 | nc-cah | 1 |
| 735 | neoplasia-bearing | 1 |
| 736 | nfv-treated | 1 |
| 737 | nitroimidazole-allergic | 1 |
| 738 | non-appendicitis | 1 |
| 739 | non-bleb-related | 1 |
| 740 | non-ketamine-sedated | 1 |
| 741 | non-msk | 1 |
| 742 | non-ranibizumab | 1 |
| 743 | non-splectomised | 1 |
| 744 | nssa | 1 |
| 745 | obliging | 1 |
| 746 | obliterant | 1 |
| 747 | oversedated | 1 |
| 748 | p2xr-mediated | 1 |
| 749 | paft-treated | 1 |
| 750 | palbociclib-treated | 1 |
| 751 | pampc-carrying | 1 |
| 752 | pcnl-treated | 1 |
| 753 | perampanel-treated | 1 |
| 754 | pi/r-treated | 1 |
| 755 | piribedil-treated | 1 |
| 756 | post-ec-tcpc | 1 |
| 757 | post-is | 1 |
| 758 | prematched | 1 |
| 759 | q4-wk-treated | 1 |
| 760 | quifenadine-treated | 1 |
| 761 | radiosurgery-treated | 1 |
| 762 | rales-eligible | 1 |
| 763 | randomised/eligible | 1 |
| 764 | rcts-after | 1 |
| 765 | receptor-in | 1 |
| 766 | rely-able-eligible | 1 |
| 767 | rhcmv-induced | 1 |
| 768 | rioprostil-treated | 1 |
| 769 | ruxolitinib-naive | 1 |
| 770 | simulators-standardized | 1 |
| 771 | snake-bitten | 1 |
| 772 | splectomised | 1 |
| 773 | state-of | 1 |
| 774 | stomaphyx-treated | 1 |
| 775 | tamoxifen-responsive | 1 |
| 776 | taspoglutide-treated | 1 |
| 777 | tcp-supplemented | 1 |
| 778 | tcz-treated | 1 |
| 779 | tdf-exposed | 1 |
| 780 | telemetry-monitored | 1 |
| 781 | temsirolimus-treated | 1 |
| 782 | thalidomide-related | 1 |
| 783 | thalidomide/bortezomib-induced | 1 |
| 784 | the1158 | 1 |
| 785 | thienoypridine-treated | 1 |
| 786 | tocilizumab-iv-treated | 1 |
| 787 | tocilizumab-sc-treated | 1 |
| 788 | tolciclate-treated | 1 |
| 789 | topotecan-treated | 1 |
| 790 | toxo-positive | 1 |
| 791 | tympanostomized | 1 |
| 792 | vhl-inactive | 1 |
| 793 | vvir-paced | 1 |
| 794 | well-sedated | 1 |
| 795 | white-coded | 1 |
| 796 | worm-infected | 1 |
| 797 | ximelagatran-treated | 1 |
| 798 | years-mostly | 1 |
| 799 | za-treated | 1 |
| 800 | zolmitriptan-treated | 1 |
| 801 | ≈830 | 1 |
| 1 | 'diabetic | 11 |
| 2 | 'uremic | 1 |
| 3 | -ischemic | 1 |
| 4 | 0.85:67 | 1 |
| 5 | 1,174,545 | 1 |
| 6 | 1,732 | 1 |
| 7 | 1,880 | 1 |
| 8 | 1,952 | 1 |
| 9 | 10,047 | 1 |
| 10 | 10,082 | 1 |
| 11 | 10,129 | 1 |
| 12 | 10,217 | 1 |
| 13 | 10,222 | 1 |
| 14 | 10,230 | 1 |
| 15 | 10,280 | 1 |
| 16 | 10,282 | 1 |
| 17 | 10,364 | 1 |
| 18 | 10,469 | 1 |
| 19 | 10,625 | 1 |
| 20 | 10,660 | 1 |
| 21 | 10,711 | 1 |
| 22 | 10,727 | 1 |
| 23 | 10,735 | 1 |
| 24 | 10,771 | 1 |
| 25 | 10,798,343 | 1 |
| 26 | 10,805 | 1 |
| 27 | 10,819 | 1 |
| 28 | 10,972 | 1 |
| 29 | 101,801 | 1 |
| 30 | 102,060 | 1 |
| 31 | 102,647 | 1 |
| 32 | 103,972 | 1 |
| 33 | 10326 | 1 |
| 34 | 104,306 | 1 |
| 35 | 109,002 | 1 |
| 36 | 109,836 | 1 |
| 37 | 11,108 | 1 |
| 38 | 11,143 | 1 |
| 39 | 11,215 | 1 |
| 40 | 11,216 | 1 |
| 41 | 11,321 | 1 |
| 42 | 11,369 | 1 |
| 43 | 11,377 | 1 |
| 44 | 11,638 | 1 |
| 45 | 11,945 | 2 |
| 46 | 111,818 | 1 |
| 47 | 11141 | 1 |
| 48 | 113,394 | 1 |
| 49 | 115,608 | 1 |
| 50 | 12,072 | 1 |
| 51 | 12,168 | 1 |
| 52 | 12,184 | 1 |
| 53 | 12,236 | 1 |
| 54 | 12,358 | 1 |
| 55 | 12,505 | 1 |
| 56 | 12,585 | 1 |
| 57 | 12,812 | 1 |
| 58 | 121,910 | 1 |
| 59 | 122,458 | 1 |
| 60 | 124,734 | 1 |
| 61 | 125,161 | 1 |
| 62 | 13,169 | 1 |
| 63 | 13,255 | 1 |
| 64 | 13,295 | 1 |
| 65 | 13,320 | 1 |
| 66 | 13,412 | 1 |
| 67 | 13,691 | 1 |
| 68 | 13,699 | 1 |
| 69 | 13,762 | 1 |
| 70 | 13,776 | 1 |
| 71 | 13,812 | 1 |
| 72 | 13,825 | 1 |
| 73 | 13,955 | 1 |
| 74 | 13269 | 1 |
| 75 | 132:66:66 | 1 |
| 76 | 13415 | 1 |
| 77 | 135,871 | 1 |
| 78 | 136/1304 | 1 |
| 79 | 137,277 | 1 |
| 80 | 14,151 | 1 |
| 81 | 14,252 | 1 |
| 82 | 14,277 | 1 |
| 83 | 14,326 | 1 |
| 84 | 14,644 | 1 |
| 85 | 14,683 | 1 |
| 86 | 14,830 | 1 |
| 87 | 14,933 | 1 |
| 88 | 14,935 | 1 |
| 89 | 14.344 | 1 |
| 90 | 142,158 | 1 |
| 91 | 15,711 | 1 |
| 92 | 15,762 | 1 |
| 93 | 152,729 | 1 |
| 94 | 155,243 | 1 |
| 95 | 156,798 | 1 |
| 96 | 156/385 | 1 |
| 97 | 16,011 | 1 |
| 98 | 16,173 | 1 |
| 99 | 16,192 | 1 |
| 100 | 16,411 | 1 |
| 101 | 16,451 | 1 |
| 102 | 16,489 | 1 |
| 103 | 16,812 | 1 |
| 104 | 16,872 | 1 |
| 105 | 16,912 | 1 |
| 106 | 16-24-year-old | 1 |
| 107 | 16-to-78-year-old | 1 |
| 108 | 161,585 | 1 |
| 109 | 163,668 | 1 |
| 110 | 164,497 | 1 |
| 111 | 167,311 | 1 |
| 112 | 167,839 | 1 |
| 113 | 167,907 | 1 |
| 114 | 169,518 | 1 |
| 115 | 17,002 | 1 |
| 116 | 17,028 | 1 |
| 117 | 17,137 | 1 |
| 118 | 17,413 | 1 |
| 119 | 17,420 | 2 |
| 120 | 17,475 | 1 |
| 121 | 17,570 | 1 |
| 122 | 17,776 | 1 |
| 123 | 17,888 | 1 |
| 124 | 17,990 | 1 |
| 125 | 17-18-year-old | 1 |
| 126 | 17029 | 1 |
| 127 | 171,885 | 1 |
| 128 | 171/309 | 1 |
| 129 | 17157 | 1 |
| 130 | 173,028 | 1 |
| 131 | 179,122 | 1 |
| 132 | 18,061 | 1 |
| 133 | 18,064 | 1 |
| 134 | 18,206 | 1 |
| 135 | 18,260 | 1 |
| 136 | 18,334 | 1 |
| 137 | 18,867 | 1 |
| 138 | 181,993 | 1 |
| 139 | 181/1000 | 1 |
| 140 | 184,480 | 1 |
| 141 | 186,663 | 1 |
| 142 | 19,013 | 1 |
| 143 | 19,735 | 1 |
| 144 | 19,756 | 2 |
| 145 | 19,826 | 1 |
| 146 | 19,867 | 1 |
| 147 | 19,942 | 1 |
| 148 | 190,664 | 1 |
| 149 | 19842 | 1 |
| 150 | 198mb | 1 |
| 151 | 2,043 | 4 |
| 152 | 2,145 | 3 |
| 153 | 2,225 | 1 |
| 154 | 2,383 | 1 |
| 155 | 2,487 | 1 |
| 156 | 2,568 | 1 |
| 157 | 2,599,685 | 1 |
| 158 | 2,633 | 1 |
| 159 | 2,660,929 | 1 |
| 160 | 2,698 | 1 |
| 161 | 2,803 | 1 |
| 162 | 2,821 | 1 |
| 163 | 2,911 | 1 |
| 164 | 20,170 | 1 |
| 165 | 20,451 | 3 |
| 166 | 20,478 | 1 |
| 167 | 20,479 | 1 |
| 168 | 20,599 | 1 |
| 169 | 20,750 | 1 |
| 170 | 20481 | 1 |
| 171 | 206,940 | 1 |
| 172 | 20618 | 1 |
| 173 | 21,062 | 1 |
| 174 | 21,379 | 1 |
| 175 | 21,533 | 1 |
| 176 | 21,946 | 1 |
| 177 | 21,972 | 1 |
| 178 | 218,043 | 1 |
| 179 | 22,052 | 1 |
| 180 | 22,063 | 2 |
| 181 | 22,094 | 1 |
| 182 | 22,274 | 1 |
| 183 | 22,275 | 1 |
| 184 | 22,525 | 1 |
| 185 | 22.239 | 1 |
| 186 | 221,799 | 1 |
| 187 | 22282 | 1 |
| 188 | 223,313 | 1 |
| 189 | 226,709 | 1 |
| 190 | 229,116 | 1 |
| 191 | 23,357 | 1 |
| 192 | 23,600 | 1 |
| 193 | 23,668 | 1 |
| 194 | 23,931 | 1 |
| 195 | 235,290 | 1 |
| 196 | 24,196 | 1 |
| 197 | 24,214 | 1 |
| 198 | 24,322 | 1 |
| 199 | 24,644 | 1 |
| 200 | 24,910 | 1 |
| 201 | 24,979 | 1 |
| 202 | 24.2/100 | 1 |
| 203 | 24.623 | 1 |
| 204 | 240,268 | 1 |
| 205 | 242,738 | 1 |
| 206 | 242/280 | 1 |
| 207 | 25,280 | 1 |
| 208 | 25,425 | 1 |
| 209 | 25,486 | 1 |
| 210 | 25,584 | 1 |
| 211 | 25,643 | 1 |
| 212 | 25340 | 1 |
| 213 | 2589 | 7 |
| 214 | 26,155 | 1 |
| 215 | 26,437 | 1 |
| 216 | 26,451 | 1 |
| 217 | 26,833 | 1 |
| 218 | 26,957 | 1 |
| 219 | 27,023 | 1 |
| 220 | 27,039 | 1 |
| 221 | 27,802 | 1 |
| 222 | 27,807 | 1 |
| 223 | 27,947 | 1 |
| 224 | 28,144 | 1 |
| 225 | 28,150 | 1 |
| 226 | 28,628 | 1 |
| 227 | 28,991 | 1 |
| 228 | 29,488 | 1 |
| 229 | 29,827 | 1 |
| 230 | 29,954 | 1 |
| 231 | 290,847 | 1 |
| 232 | 298/362 | 1 |
| 233 | 2989 | 4 |
| 234 | 3,075 | 1 |
| 235 | 3,095 | 2 |
| 236 | 3,104 | 1 |
| 237 | 3,121 | 1 |
| 238 | 3,171 | 1 |
| 239 | 3,181 | 1 |
| 240 | 3,286 | 1 |
| 241 | 3,373 | 1 |
| 242 | 3,508 | 1 |
| 243 | 3,570 | 1 |
| 244 | 3,641 | 1 |
| 245 | 3,672 | 2 |
| 246 | 3,678,868 | 1 |
| 247 | 3,724 | 1 |
| 248 | 3,737 | 1 |
| 249 | 3,782 | 2 |
| 250 | 3,798 | 1 |
| 251 | 3,904 | 1 |
| 252 | 3,991 | 2 |
| 253 | 3.600 | 1 |
| 254 | 30,076 | 1 |
| 255 | 30,139 | 1 |
| 256 | 30,348 | 1 |
| 257 | 30,561 | 1 |
| 258 | 31,020 | 1 |
| 259 | 32,025 | 1 |
| 260 | 32,258 | 2 |
| 261 | 32,707 | 1 |
| 262 | 32,795 | 1 |
| 263 | 32,919 | 1 |
| 264 | 33,238 | 1 |
| 265 | 33,356 | 1 |
| 266 | 33,429 | 1 |
| 267 | 33,669 | 1 |
| 268 | 3337 | 7 |
| 269 | 338,191 | 1 |
| 270 | 33885 | 1 |
| 271 | 34,122 | 1 |
| 272 | 34,533 | 1 |
| 273 | 3416 | 4 |
| 274 | 35,239 | 1 |
| 275 | 350,031 | 1 |
| 276 | 3507 | 6 |
| 277 | 36,489 | 1 |
| 278 | 36,869 | 1 |
| 279 | 37,010 | 1 |
| 280 | 37,229 | 1 |
| 281 | 37,515 | 1 |
| 282 | 37,695 | 1 |
| 283 | 374,068 | 1 |
| 284 | 38,072 | 1 |
| 285 | 38,385 | 1 |
| 286 | 38,439 | 1 |
| 287 | 39030 | 1 |
| 288 | 3905 | 1 |
| 289 | 3997 | 2 |
| 290 | 4,006 | 1 |
| 291 | 4,155 | 2 |
| 292 | 4,165 | 1 |
| 293 | 4,225 | 1 |
| 294 | 4,302 | 1 |
| 295 | 4,459 | 1 |
| 296 | 4,498 | 1 |
| 297 | 4,609 | 1 |
| 298 | 4,763 | 2 |
| 299 | 4,814 | 1 |
| 300 | 4,872 | 1 |
| 301 | 40,028 | 1 |
| 302 | 40,907 | 1 |
| 303 | 4048 | 1 |
| 304 | 408/1000 | 1 |
| 305 | 41,088 | 1 |
| 306 | 41,479 | 1 |
| 307 | 41,976 | 1 |
| 308 | 415,409 | 1 |
| 309 | 42,016 | 1 |
| 310 | 43,305 | 1 |
| 311 | 43,410 | 1 |
| 312 | 43,625 | 1 |
| 313 | 43,904 | 1 |
| 314 | 44,012 | 1 |
| 315 | 44,948 | 1 |
| 316 | 45,247 | 1 |
| 317 | 451/15,203 | 1 |
| 318 | 46,991 | 2 |
| 319 | 4617 | 2 |
| 320 | 4649 | 1 |
| 321 | 47,148 | 1 |
| 322 | 48,599 | 1 |
| 323 | 48,950 | 1 |
| 324 | 480,942 | 1 |
| 325 | 48248 | 1 |
| 326 | 4859 | 1 |
| 327 | 49,275 | 1 |
| 328 | 49,599 | 1 |
| 329 | 49,697 | 1 |
| 330 | 490,000 | 1 |
| 331 | 4960 | 3 |
| 332 | 499,593 | 1 |
| 333 | 4998 | 1 |
| 334 | 5,118 | 1 |
| 335 | 5,207 | 1 |
| 336 | 5,239 | 1 |
| 337 | 5,332 | 1 |
| 338 | 5,477 | 1 |
| 339 | 5,491 | 1 |
| 340 | 5,526 | 1 |
| 341 | 5,587 | 1 |
| 342 | 5,592 | 1 |
| 343 | 5,716 | 1 |
| 344 | 5,792 | 1 |
| 345 | 5,833 | 1 |
| 346 | 5,889 | 1 |
| 347 | 50,025 | 1 |
| 348 | 50,242 | 1 |
| 349 | 5078 | 1 |
| 350 | 51,303 | 1 |
| 351 | 51/80 | 1 |
| 352 | 51895 | 1 |
| 353 | 52,010 | 1 |
| 354 | 52,647 | 1 |
| 355 | 52,778 | 1 |
| 356 | 5295 | 1 |
| 357 | 54,453 | 1 |
| 358 | 54174 | 1 |
| 359 | 5458 | 1 |
| 360 | 5492 | 1 |
| 361 | 5590 | 1 |
| 362 | 56,031 | 1 |
| 363 | 56,561 | 1 |
| 364 | 565,016 | 1 |
| 365 | 5652 | 1 |
| 366 | 5659 | 1 |
| 367 | 57,246 | 1 |
| 368 | 57,491 | 1 |
| 369 | 5720 | 1 |
| 370 | 5737 | 1 |
| 371 | 5754 | 1 |
| 372 | 579,521 | 1 |
| 373 | 5799 | 3 |
| 374 | 58,009 | 1 |
| 375 | 5802 | 1 |
| 376 | 5814 | 2 |
| 377 | 584,784 | 1 |
| 378 | 5856 | 1 |
| 379 | 5877 | 1 |
| 380 | 5880 | 1 |
| 381 | 5899 | 1 |
| 382 | 59,004 | 1 |
| 383 | 59,233 | 1 |
| 384 | 599,141 | 1 |
| 385 | 6,065 | 1 |
| 386 | 6,105 | 1 |
| 387 | 6,162 | 1 |
| 388 | 6,191 | 1 |
| 389 | 6,196 | 1 |
| 390 | 6,236 | 1 |
| 391 | 6,271 | 1 |
| 392 | 6,336 | 1 |
| 393 | 6,346 | 1 |
| 394 | 6,367 | 1 |
| 395 | 6,377 | 1 |
| 396 | 6,430 | 1 |
| 397 | 6,483 | 1 |
| 398 | 6,496 | 1 |
| 399 | 6,514 | 1 |
| 400 | 6,524 | 1 |
| 401 | 6,563 | 1 |
| 402 | 6,750 | 1 |
| 403 | 6,776 | 1 |
| 404 | 6,778 | 1 |
| 405 | 6,910 | 1 |
| 406 | 60,386 | 1 |
| 407 | 600/1,094 | 1 |
| 408 | 602,222 | 1 |
| 409 | 6152 | 1 |
| 410 | 6158 | 1 |
| 411 | 6194 | 1 |
| 412 | 623,358 | 1 |
| 413 | 6289 | 1 |
| 414 | 6345 | 1 |
| 415 | 6363 | 1 |
| 416 | 64,387 | 1 |
| 417 | 6401 | 1 |
| 418 | 6409 | 1 |
| 419 | 6516 | 1 |
| 420 | 6549 | 1 |
| 421 | 6558 | 3 |
| 422 | 67,851 | 1 |
| 423 | 6738 | 1 |
| 424 | 6774 | 1 |
| 425 | 68,236 | 1 |
| 426 | 681,122 | 1 |
| 427 | 6810 | 1 |
| 428 | 682,993 | 1 |
| 429 | 6844 | 1 |
| 430 | 6873 | 1 |
| 431 | 6876 | 2 |
| 432 | 69,060 | 1 |
| 433 | 69,958 | 2 |
| 434 | 6905 | 1 |
| 435 | 6942 | 1 |
| 436 | 6963 | 1 |
| 437 | 7,414 | 1 |
| 438 | 7,540 | 1 |
| 439 | 7,619 | 1 |
| 440 | 7,648 | 1 |
| 441 | 7,793 | 1 |
| 442 | 7,974 | 1 |
| 443 | 7,994 | 1 |
| 444 | 7/58 | 2 |
| 445 | 70,403 | 1 |
| 446 | 70,500 | 1 |
| 447 | 70,764 | 1 |
| 448 | 7135 | 1 |
| 449 | 7186 | 1 |
| 450 | 72,597 | 1 |
| 451 | 72/173 | 1 |
| 452 | 7226 | 1 |
| 453 | 7240 | 1 |
| 454 | 73,012 | 1 |
| 455 | 7472 | 1 |
| 456 | 7489 | 1 |
| 457 | 7499 | 1 |
| 458 | 75,086 | 1 |
| 459 | 75,873 | 1 |
| 460 | 7576 | 2 |
| 461 | 76,397 | 1 |
| 462 | 7640 | 1 |
| 463 | 77,552 | 1 |
| 464 | 7754 | 1 |
| 465 | 7783 | 1 |
| 466 | 78,230 | 1 |
| 467 | 7924 | 1 |
| 468 | 7956 | 1 |
| 469 | 8,015 | 1 |
| 470 | 8,216 | 1 |
| 471 | 8,252 | 1 |
| 472 | 8,424 | 1 |
| 473 | 8,443 | 1 |
| 474 | 8,515 | 1 |
| 475 | 8,528 | 1 |
| 476 | 8,695 | 1 |
| 477 | 8,708 | 1 |
| 478 | 8,771 | 1 |
| 479 | 8,785 | 1 |
| 480 | 8,909 | 1 |
| 481 | 8,988 | 1 |
| 482 | 8.666 | 1 |
| 483 | 80,290 | 1 |
| 484 | 8004 | 1 |
| 485 | 81,081 | 1 |
| 486 | 81,649 | 1 |
| 487 | 8158 | 1 |
| 488 | 81788 | 1 |
| 489 | 82,018 | 1 |
| 490 | 82,784 | 1 |
| 491 | 8204 | 1 |
| 492 | 83,953 | 1 |
| 493 | 8504 | 2 |
| 494 | 8519 | 1 |
| 495 | 8555 | 1 |
| 496 | 86,598 | 1 |
| 497 | 8653 | 2 |
| 498 | 8682 | 1 |
| 499 | 8718 | 1 |
| 500 | 8880 | 1 |
| 501 | 89,703 | 1 |
| 502 | 8940 | 2 |
| 503 | 8988 | 1 |
| 504 | 8990 | 1 |
| 505 | 9,027 | 1 |
| 506 | 9,080 | 1 |
| 507 | 9,124 | 1 |
| 508 | 9,138 | 1 |
| 509 | 9,187 | 1 |
| 510 | 9,297 | 1 |
| 511 | 9,325 | 1 |
| 512 | 9,393 | 1 |
| 513 | 9,405 | 1 |
| 514 | 9,496 | 1 |
| 515 | 9,513 | 1 |
| 516 | 9,704 | 1 |
| 517 | 90,480 | 1 |
| 518 | 9004 | 1 |
| 519 | 9016 | 1 |
| 520 | 9020 | 1 |
| 521 | 9199 | 1 |
| 522 | 9295 | 1 |
| 523 | 93,451 | 1 |
| 524 | 9388 | 1 |
| 525 | 94,558 | 1 |
| 526 | 94,785 | 1 |
| 527 | 9441 | 1 |
| 528 | 9510 | 1 |
| 529 | 9519 | 1 |
| 530 | 96.022 | 1 |
| 531 | 97,458 | 1 |
| 532 | 9753 | 1 |
| 533 | 9766 | 1 |
| 534 | 98,869 | 1 |
| 535 | 9838 | 1 |
| 536 | 9861 | 1 |
| 537 | 9948 | 1 |
| 538 | a10-treated | 1 |
| 539 | a5-treated | 1 |
| 540 | acalculic | 1 |
| 541 | acne-scarred | 1 |
| 542 | adalimumab-randomised | 3 |
| 543 | adefovir-treated | 1 |
| 544 | adherent/non-adherent | 1 |
| 545 | adhesion-free | 1 |
| 546 | afatinib-treated | 3 |
| 547 | age-and-sex-matched | 1 |
| 548 | alda-eligible | 1 |
| 549 | allogeneic-hct | 4 |
| 550 | almotriptan-treated | 1 |
| 551 | alt-elevating | 1 |
| 552 | ambd-treated | 1 |
| 553 | ami-hospitalized | 1 |
| 554 | amyloid-positive | 5 |
| 555 | amyloidotic | 15 |
| 556 | antecedes | 1 |
| 557 | arb/acei | 1 |
| 558 | aspirin-allocated | 1 |
| 559 | atnf-naive | 1 |
| 560 | atovaquone-proguanil-treated | 1 |
| 561 | auto-antibody-positive | 1 |
| 562 | avv-tenos-transduced | 1 |
| 563 | aztreonam-treated | 2 |
| 564 | bacteria-negative | 2 |
| 565 | biomarker-evaluated | 1 |
| 566 | boceprevir-treated | 1 |
| 567 | bortezomib-induced | 13 |
| 568 | c-ses-treated | 1 |
| 569 | ca125-positive | 1 |
| 570 | cabg-eligible | 1 |
| 571 | cabozantinib-treated | 1 |
| 572 | cae-treated | 1 |
| 573 | capcaa-associated | 1 |
| 574 | carboplatin/paclitaxel-induced | 1 |
| 575 | cardiac-stable | 1 |
| 576 | carrageenan-treated | 3 |
| 577 | caspofungin-treated | 4 |
| 578 | cat-allergic | 3 |
| 579 | cbz-erc-treated | 1 |
| 580 | cd16+/ido+-expressing | 1 |
| 581 | cefprozil-treated | 2 |
| 582 | cfa-negative | 1 |
| 583 | cgrp-immunopositive | 1 |
| 584 | chagasic | 73 |
| 585 | chemotherapy-evoked | 1 |
| 586 | chronically-infected | 2 |
| 587 | cirrhotic | 605 |
| 588 | cisca-treated | 1 |
| 589 | cldn16-related | 1 |
| 590 | cnis-treated | 1 |
| 591 | corneoconjunctival | 1 |
| 592 | cryoblation | 1 |
| 593 | ctc/ml | 1 |
| 594 | cysticercotic | 1 |
| 595 | cytokine-expressing | 1 |
| 596 | dacarbazine-treated | 1 |
| 597 | daclatasvir-treated | 1 |
| 598 | darbepoetin-treated | 2 |
| 599 | darunavir/ritonavir-treated | 1 |
| 600 | dcf-induced | 1 |
| 601 | death/105 | 1 |
| 602 | des-treated | 7 |
| 603 | detemir-treated | 1 |
| 604 | dhea-substituted | 1 |
| 605 | dhp-treated | 1 |
| 606 | di-abetic | 1 |
| 607 | diabetic | 14,345 |
| 608 | diabetic- | 1 |
| 609 | diabetic-hypercholesterolemic | 4 |
| 610 | diphenhydramine-treated | 1 |
| 611 | dipstick-positive | 8 |
| 612 | doctor-referred | 1 |
| 613 | dysmennorheic | 1 |
| 614 | earth-bound | 1 |
| 615 | emergency-related | 3 |
| 616 | enoxaparin/vka-treated | 1 |
| 617 | ertapenem-treated | 1 |
| 618 | erythropoietin-naive | 1 |
| 619 | esmolol-treated | 6 |
| 620 | euro-canadian | 1 |
| 621 | ex-smokers/never-smoked | 1 |
| 622 | ex16 | 7 |
| 623 | females/1 | 1 |
| 624 | fibrinolysis-treated | 1 |
| 625 | fibrocaps-treated | 2 |
| 626 | fidaxomicin-treated | 3 |
| 627 | flat-arched | 1 |
| 628 | fluorouracil-refractory | 1 |
| 629 | fractures.twenty-four | 1 |
| 630 | fructose-fed | 43 |
| 631 | gada-positive | 1 |
| 632 | gbp-treated | 1 |
| 633 | gde-free | 1 |
| 634 | giop-eligible | 1 |
| 635 | giop-treated | 1 |
| 636 | gonorrhea-infected | 1 |
| 637 | good-mr | 1 |
| 638 | good-ps | 1 |
| 639 | group,12 | 1 |
| 640 | group,15 | 1 |
| 641 | half-blooded | 1 |
| 642 | health.gonococcal | 1 |
| 643 | heat-affected | 3 |
| 644 | hec-treated | 1 |
| 645 | helicobacter-infected | 2 |
| 646 | hep-treated | 1 |
| 647 | hfd-fed | 34 |
| 648 | hidac-3-treated | 1 |
| 649 | high-utilization | 1 |
| 650 | hiv-/hcv-coinfected | 1 |
| 651 | hlcat+/ldlr-/- | 2 |
| 652 | hmg-coa-reductase-induced | 1 |
| 653 | hmpl-004-treated | 2 |
| 654 | hn-allergic | 1 |
| 655 | homokaryotypic | 1 |
| 656 | hospitalized-manic | 1 |
| 657 | htupa-treated | 1 |
| 658 | i150/a10-treated | 1 |
| 659 | i150/a5-treated | 1 |
| 660 | i300-treated | 1 |
| 661 | i300/a5-treated | 1 |
| 662 | ibrutinib-treated | 1 |
| 663 | icu-treated | 1 |
| 664 | ihc+ | 1 |
| 665 | imatinib-naïve | 1 |
| 666 | imipenem/cilastatin-treated | 1 |
| 667 | infliximab-to-abatacept | 2 |
| 668 | inoperable/high-risk | 2 |
| 669 | insulin-eligible | 2 |
| 670 | intetumumab-treated | 1 |
| 671 | invasion-supporting | 1 |
| 672 | ischemic-dilated | 1 |
| 673 | itraconazole-treated | 3 |
| 674 | ket-induced | 3 |
| 675 | lamivudin-refractory | 1 |
| 676 | latero-frontal | 1 |
| 677 | ldt-treated | 1 |
| 678 | leukapheresed | 1 |
| 679 | lfn-naive | 1 |
| 680 | life-diabetic | 2 |
| 681 | long-surviving | 3 |
| 682 | lopinavir/ritonavir-treated | 1 |
| 683 | low-impulsive | 2 |
| 684 | low-mobile | 4 |
| 685 | lower-priority | 1 |
| 686 | lupic | 2 |
| 687 | lvd-treated | 1 |
| 688 | m-csf-treated | 1 |
| 689 | maximally-treated | 1 |
| 690 | mdma-treated | 6 |
| 691 | mericitabine-treated | 1 |
| 692 | merit-hf-eligible | 1 |
| 693 | mg-depleted | 3 |
| 694 | micafungin-treated | 1 |
| 695 | mustt-enrolled | 1 |
| 696 | mustt/madit-type | 1 |
| 697 | mvac-treated | 1 |
| 698 | myrrh-treated | 2 |
| 699 | n=6259 | 1 |
| 700 | nafld-suspected | 1 |
| 701 | naproxen-treated | 7 |
| 702 | nausea-free | 1 |
| 703 | nc-cah | 1 |
| 704 | neoplasia-bearing | 1 |
| 705 | nfv-treated | 1 |
| 706 | nitroimidazole-allergic | 1 |
| 707 | nitroprusside-treated | 2 |
| 708 | non-appendicitis | 1 |
| 709 | non-bleb-related | 1 |
| 710 | non-entered | 3 |
| 711 | non-immunocompromized | 2 |
| 712 | non-ketamine-sedated | 1 |
| 713 | non-msk | 1 |
| 714 | non-ranibizumab | 1 |
| 715 | non-splectomised | 1 |
| 716 | non-transplant | 19 |
| 717 | nonburn | 3 |
| 718 | nonstroke | 14 |
| 719 | nsaids-induced | 4 |
| 720 | nssa | 1 |
| 721 | obliging | 1 |
| 722 | obliterant | 1 |
| 723 | op-poisoned | 2 |
| 724 | oversedated | 1 |
| 725 | oxaliplatin-treated | 4 |
| 726 | p2xr-mediated | 1 |
| 727 | paft-treated | 1 |
| 728 | palbociclib-treated | 1 |
| 729 | pampc-carrying | 1 |
| 730 | pcnl-treated | 1 |
| 731 | pcr-diagnosed | 2 |
| 732 | perampanel-treated | 1 |
| 733 | pheochromocytoma-induced | 2 |
| 734 | pi/r-treated | 1 |
| 735 | piribedil-treated | 1 |
| 736 | post-ec-tcpc | 1 |
| 737 | post-is | 1 |
| 738 | prematched | 1 |
| 739 | ptps-deficient | 3 |
| 740 | q4-wk-treated | 1 |
| 741 | quifenadine-treated | 1 |
| 742 | radiosurgery-treated | 1 |
| 743 | rales-eligible | 1 |
| 744 | randomised/eligible | 1 |
| 745 | rcts-after | 1 |
| 746 | receptor-in | 1 |
| 747 | rely-able-eligible | 1 |
| 748 | rhcmv-induced | 1 |
| 749 | rilonacept-treated | 2 |
| 750 | rioprostil-treated | 1 |
| 751 | romiplostim-treated | 10 |
| 752 | ruxolitinib-naive | 1 |
| 753 | savr-treated | 2 |
| 754 | sca3-associated | 2 |
| 755 | scoliotic | 17 |
| 756 | simeprevir/pr-treated | 2 |
| 757 | simulators-standardized | 1 |
| 758 | sipuleucel-t-treated | 2 |
| 759 | smv-treated | 2 |
| 760 | snake-bitten | 1 |
| 761 | solvd-eligible | 2 |
| 762 | splectomised | 1 |
| 763 | srl-treated | 5 |
| 764 | state-of | 1 |
| 765 | stomaphyx-treated | 1 |
| 766 | sulconazole-treated | 2 |
| 767 | sumatriptan-treated | 4 |
| 768 | tamoxifen-responsive | 1 |
| 769 | taspoglutide-treated | 1 |
| 770 | tcp-supplemented | 1 |
| 771 | tcz-treated | 1 |
| 772 | tdf-exposed | 1 |
| 773 | telemetry-monitored | 1 |
| 774 | temsirolimus-treated | 1 |
| 775 | tgab-positive | 5 |
| 776 | thalidomide-related | 1 |
| 777 | thalidomide/bortezomib-induced | 1 |
| 778 | the1158 | 1 |
| 779 | thienoypridine-treated | 1 |
| 780 | thrombolysis-eligible | 3 |
| 781 | tocilizumab-iv-treated | 1 |
| 782 | tocilizumab-sc-treated | 1 |
| 783 | tolciclate-treated | 1 |
| 784 | topotecan-treated | 1 |
| 785 | toxo-positive | 1 |
| 786 | tpm-treated | 3 |
| 787 | troglitazone-treated | 7 |
| 788 | tympanostomized | 1 |
| 789 | ultrasonographic-guided | 2 |
| 790 | vascular-complicated | 2 |
| 791 | vhl-inactive | 1 |
| 792 | vigabatrin-exposed | 2 |
| 793 | vvir-paced | 1 |
| 794 | well-sedated | 1 |
| 795 | white-coded | 1 |
| 796 | worm-infected | 1 |
| 797 | ximelagatran-treated | 1 |
| 798 | years-mostly | 1 |
| 799 | za-treated | 1 |
| 800 | zolmitriptan-treated | 1 |
| 801 | ≈830 | 1 |
| 1 | ihc+ | 1 |
| 2 | hlcat+/ldlr-/- | 2 |
| 3 | diabetic- | 1 |
| 4 | 490,000 | 1 |
| 5 | 181/1000 | 1 |
| 6 | 408/1000 | 1 |
| 7 | 24.2/100 | 1 |
| 8 | 70,500 | 1 |
| 9 | 23,600 | 1 |
| 10 | 3.600 | 1 |
| 11 | 52,010 | 1 |
| 12 | 37,010 | 1 |
| 13 | 43,410 | 1 |
| 14 | 9510 | 1 |
| 15 | 6810 | 1 |
| 16 | 121,910 | 1 |
| 17 | 24,910 | 1 |
| 18 | 6,910 | 1 |
| 19 | 31,020 | 1 |
| 20 | 9020 | 1 |
| 21 | 13,320 | 1 |
| 22 | 17,420 | 2 |
| 23 | 5720 | 1 |
| 24 | 39030 | 1 |
| 25 | 10,230 | 1 |
| 26 | 78,230 | 1 |
| 27 | 6,430 | 1 |
| 28 | 14,830 | 1 |
| 29 | ≈830 | 1 |
| 30 | 7240 | 1 |
| 31 | 25340 | 1 |
| 32 | 7,540 | 1 |
| 33 | 7640 | 1 |
| 34 | 206,940 | 1 |
| 35 | 8940 | 2 |
| 36 | 28,150 | 1 |
| 37 | 20,750 | 1 |
| 38 | 6,750 | 1 |
| 39 | 48,950 | 1 |
| 40 | 102,060 | 1 |
| 41 | 69,060 | 1 |
| 42 | 18,260 | 1 |
| 43 | 10,660 | 1 |
| 44 | 4960 | 3 |
| 45 | 20,170 | 1 |
| 46 | 3,570 | 1 |
| 47 | 17,570 | 1 |
| 48 | 51/80 | 1 |
| 49 | 9,080 | 1 |
| 50 | 10,280 | 1 |
| 51 | 25,280 | 1 |
| 52 | 242/280 | 1 |
| 53 | 90,480 | 1 |
| 54 | 184,480 | 1 |
| 55 | 1,880 | 1 |
| 56 | 5880 | 1 |
| 57 | 8880 | 1 |
| 58 | 80,290 | 1 |
| 59 | 235,290 | 1 |
| 60 | 5590 | 1 |
| 61 | 17,990 | 1 |
| 62 | 8990 | 1 |
| 63 | females/1 | 1 |
| 64 | 6401 | 1 |
| 65 | 101,801 | 1 |
| 66 | 16,011 | 1 |
| 67 | 167,311 | 1 |
| 68 | 16,411 | 1 |
| 69 | 10,711 | 1 |
| 70 | 15,711 | 1 |
| 71 | 2,911 | 1 |
| 72 | 3,121 | 1 |
| 73 | 11,321 | 1 |
| 74 | 579,521 | 1 |
| 75 | 2,821 | 1 |
| 76 | 350,031 | 1 |
| 77 | 56,031 | 1 |
| 78 | 23,931 | 1 |
| 79 | 599,141 | 1 |
| 80 | 11141 | 1 |
| 81 | 9441 | 1 |
| 82 | 3,641 | 1 |
| 83 | 14,151 | 1 |
| 84 | 20,451 | 3 |
| 85 | 93,451 | 1 |
| 86 | 16,451 | 1 |
| 87 | 26,451 | 1 |
| 88 | 67,851 | 1 |
| 89 | 18,061 | 1 |
| 90 | 125,161 | 1 |
| 91 | 30,561 | 1 |
| 92 | 56,561 | 1 |
| 93 | 9861 | 1 |
| 94 | 3,171 | 1 |
| 95 | 6,271 | 1 |
| 96 | 10,771 | 1 |
| 97 | 8,771 | 1 |
| 98 | 135,871 | 1 |
| 99 | 81,081 | 1 |
| 100 | 3,181 | 1 |
| 101 | 20481 | 1 |
| 102 | 6,191 | 1 |
| 103 | 338,191 | 1 |
| 104 | 5,491 | 1 |
| 105 | 57,491 | 1 |
| 106 | 13,691 | 1 |
| 107 | 3,991 | 2 |
| 108 | 46,991 | 2 |
| 109 | 28,991 | 1 |
| 110 | 17,002 | 1 |
| 111 | 109,002 | 1 |
| 112 | 4,302 | 1 |
| 113 | 27,802 | 1 |
| 114 | 5802 | 1 |
| 115 | group,12 | 1 |
| 116 | 73,012 | 1 |
| 117 | 44,012 | 1 |
| 118 | 13,412 | 1 |
| 119 | 12,812 | 1 |
| 120 | 13,812 | 1 |
| 121 | 16,812 | 1 |
| 122 | 16,912 | 1 |
| 123 | 96.022 | 1 |
| 124 | 681,122 | 1 |
| 125 | 34,122 | 1 |
| 126 | 179,122 | 1 |
| 127 | 10,222 | 1 |
| 128 | 602,222 | 1 |
| 129 | 24,322 | 1 |
| 130 | 5,332 | 1 |
| 131 | 1,732 | 1 |
| 132 | 50,242 | 1 |
| 133 | 19842 | 1 |
| 134 | 480,942 | 1 |
| 135 | 19,942 | 1 |
| 136 | 6942 | 1 |
| 137 | 22,052 | 1 |
| 138 | 6152 | 1 |
| 139 | 14,252 | 1 |
| 140 | 8,252 | 1 |
| 141 | 77,552 | 1 |
| 142 | 5652 | 1 |
| 143 | 1,952 | 1 |
| 144 | 21,062 | 1 |
| 145 | 6,162 | 1 |
| 146 | 298/362 | 1 |
| 147 | 13,762 | 1 |
| 148 | 15,762 | 1 |
| 149 | 12,072 | 1 |
| 150 | 38,072 | 1 |
| 151 | 7472 | 1 |
| 152 | 3,672 | 2 |
| 153 | 4,872 | 1 |
| 154 | 16,872 | 1 |
| 155 | 10,972 | 1 |
| 156 | 21,972 | 1 |
| 157 | 103,972 | 1 |
| 158 | 10,082 | 1 |
| 159 | 10,282 | 1 |
| 160 | 22282 | 1 |
| 161 | 8682 | 1 |
| 162 | 3,782 | 2 |
| 163 | 16,192 | 1 |
| 164 | 5492 | 1 |
| 165 | 5,592 | 1 |
| 166 | 5,792 | 1 |
| 167 | 451/15,203 | 1 |
| 168 | 51,303 | 1 |
| 169 | 70,403 | 1 |
| 170 | 89,703 | 1 |
| 171 | 2,803 | 1 |
| 172 | 19,013 | 1 |
| 173 | 223,313 | 1 |
| 174 | 17,413 | 1 |
| 175 | 9,513 | 1 |
| 176 | 27,023 | 1 |
| 177 | 24.623 | 1 |
| 178 | 59,233 | 1 |
| 179 | 21,533 | 1 |
| 180 | 34,533 | 1 |
| 181 | 2,633 | 1 |
| 182 | 5,833 | 1 |
| 183 | 26,833 | 1 |
| 184 | 14,933 | 1 |
| 185 | 2,043 | 4 |
| 186 | 218,043 | 1 |
| 187 | 11,143 | 1 |
| 188 | 155,243 | 1 |
| 189 | 10,798,343 | 1 |
| 190 | 8,443 | 1 |
| 191 | 25,643 | 1 |
| 192 | 54,453 | 1 |
| 193 | 8653 | 2 |
| 194 | 9753 | 1 |
| 195 | 83,953 | 1 |
| 196 | 22,063 | 2 |
| 197 | 6363 | 1 |
| 198 | 6,563 | 1 |
| 199 | 186,663 | 1 |
| 200 | 4,763 | 2 |
| 201 | 6963 | 1 |
| 202 | 16,173 | 1 |
| 203 | 72/173 | 1 |
| 204 | 3,373 | 1 |
| 205 | 75,873 | 1 |
| 206 | 6873 | 1 |
| 207 | 2,383 | 1 |
| 208 | 6,483 | 1 |
| 209 | 14,683 | 1 |
| 210 | 7783 | 1 |
| 211 | 9,393 | 1 |
| 212 | 499,593 | 1 |
| 213 | 7,793 | 1 |
| 214 | 181,993 | 1 |
| 215 | 682,993 | 1 |
| 216 | 59,004 | 1 |
| 217 | 8004 | 1 |
| 218 | 9004 | 1 |
| 219 | 3,104 | 1 |
| 220 | 8204 | 1 |
| 221 | 136/1304 | 1 |
| 222 | 8504 | 2 |
| 223 | 9,704 | 1 |
| 224 | 3,904 | 1 |
| 225 | 43,904 | 1 |
| 226 | 24,214 | 1 |
| 227 | 7,414 | 1 |
| 228 | 6,514 | 1 |
| 229 | 4,814 | 1 |
| 230 | 5814 | 2 |
| 231 | 9,124 | 1 |
| 232 | 8,424 | 1 |
| 233 | 6,524 | 1 |
| 234 | 3,724 | 1 |
| 235 | 7924 | 1 |
| 236 | 18,334 | 1 |
| 237 | 124,734 | 1 |
| 238 | 28,144 | 1 |
| 239 | 14.344 | 1 |
| 240 | 14,644 | 1 |
| 241 | 24,644 | 1 |
| 242 | 6844 | 1 |
| 243 | 5754 | 1 |
| 244 | 7754 | 1 |
| 245 | 29,954 | 1 |
| 246 | 18,064 | 1 |
| 247 | 10,364 | 1 |
| 248 | 190,664 | 1 |
| 249 | 70,764 | 1 |
| 250 | 54174 | 1 |
| 251 | 22,274 | 1 |
| 252 | 6774 | 1 |
| 253 | 7,974 | 1 |
| 254 | 12,184 | 1 |
| 255 | 25,584 | 1 |
| 256 | 82,784 | 1 |
| 257 | 584,784 | 1 |
| 258 | 600/1,094 | 1 |
| 259 | 22,094 | 1 |
| 260 | 6194 | 1 |
| 261 | 113,394 | 1 |
| 262 | 7,994 | 1 |
| 263 | 6,105 | 1 |
| 264 | death/105 | 1 |
| 265 | 43,305 | 1 |
| 266 | 9,405 | 1 |
| 267 | 12,505 | 1 |
| 268 | 10,805 | 1 |
| 269 | 3905 | 1 |
| 270 | 6905 | 1 |
| 271 | group,15 | 1 |
| 272 | 8,015 | 1 |
| 273 | 11,215 | 1 |
| 274 | 13415 | 1 |
| 275 | 37,515 | 1 |
| 276 | 8,515 | 1 |
| 277 | 50,025 | 1 |
| 278 | 32,025 | 1 |
| 279 | 2,225 | 1 |
| 280 | 4,225 | 1 |
| 281 | 9,325 | 1 |
| 282 | 25,425 | 1 |
| 283 | 22,525 | 1 |
| 284 | 10,625 | 1 |
| 285 | 43,625 | 1 |
| 286 | 13,825 | 1 |
| 287 | 7135 | 1 |
| 288 | 10,735 | 1 |
| 289 | 19,735 | 1 |
| 290 | 14,935 | 1 |
| 291 | 2,145 | 3 |
| 292 | 6345 | 1 |
| 293 | 1,174,545 | 1 |
| 294 | 11,945 | 2 |
| 295 | 4,155 | 2 |
| 296 | 26,155 | 1 |
| 297 | 13,255 | 1 |
| 298 | 8555 | 1 |
| 299 | 13,955 | 1 |
| 300 | 6,065 | 1 |
| 301 | 4,165 | 1 |
| 302 | 3,075 | 1 |
| 303 | 22,275 | 1 |
| 304 | 49,275 | 1 |
| 305 | 17,475 | 1 |
| 306 | 38,385 | 1 |
| 307 | 156/385 | 1 |
| 308 | 161,585 | 1 |
| 309 | 12,585 | 1 |
| 310 | 2,599,685 | 1 |
| 311 | 94,785 | 1 |
| 312 | 8,785 | 1 |
| 313 | 171,885 | 1 |
| 314 | 33885 | 1 |
| 315 | 3,095 | 2 |
| 316 | 13,295 | 1 |
| 317 | 5295 | 1 |
| 318 | 9295 | 1 |
| 319 | 37,695 | 1 |
| 320 | 8,695 | 1 |
| 321 | 32,795 | 1 |
| 322 | 51895 | 1 |
| 323 | 4,006 | 1 |
| 324 | 18,206 | 1 |
| 325 | 104,306 | 1 |
| 326 | 42,016 | 1 |
| 327 | 565,016 | 1 |
| 328 | 9016 | 1 |
| 329 | 229,116 | 1 |
| 330 | 11,216 | 1 |
| 331 | 8,216 | 1 |
| 332 | 3416 | 4 |
| 333 | 6516 | 1 |
| 334 | 5,716 | 1 |
| 335 | ex16 | 7 |
| 336 | 7226 | 1 |
| 337 | 14,326 | 1 |
| 338 | 10326 | 1 |
| 339 | 5,526 | 1 |
| 340 | 19,826 | 1 |
| 341 | 12,236 | 1 |
| 342 | 6,236 | 1 |
| 343 | 68,236 | 1 |
| 344 | 6,336 | 1 |
| 345 | 109,836 | 1 |
| 346 | 57,246 | 1 |
| 347 | 6,346 | 1 |
| 348 | 21,946 | 1 |
| 349 | 33,356 | 1 |
| 350 | 19,756 | 2 |
| 351 | 5856 | 1 |
| 352 | 7956 | 1 |
| 353 | 8.666 | 1 |
| 354 | 9766 | 1 |
| 355 | 132:66:66 | 1 |
| 356 | 30,076 | 1 |
| 357 | 7576 | 2 |
| 358 | 13,776 | 1 |
| 359 | 6,776 | 1 |
| 360 | 17,776 | 1 |
| 361 | 6876 | 2 |
| 362 | 41,976 | 1 |
| 363 | 75,086 | 1 |
| 364 | 7186 | 1 |
| 365 | 3,286 | 1 |
| 366 | 60,386 | 1 |
| 367 | 25,486 | 1 |
| 368 | 24,196 | 1 |
| 369 | 6,196 | 1 |
| 370 | 6,496 | 1 |
| 371 | 9,496 | 1 |
| 372 | 5,207 | 1 |
| 373 | 3507 | 6 |
| 374 | 32,707 | 1 |
| 375 | 27,807 | 1 |
| 376 | 40,907 | 1 |
| 377 | 167,907 | 1 |
| 378 | 10,217 | 1 |
| 379 | 4617 | 2 |
| 380 | 9,027 | 1 |
| 381 | 10,727 | 1 |
| 382 | 29,827 | 1 |
| 383 | 17,137 | 1 |
| 384 | 3337 | 7 |
| 385 | 26,437 | 1 |
| 386 | 3,737 | 1 |
| 387 | 5737 | 1 |
| 388 | 10,047 | 1 |
| 389 | 45,247 | 1 |
| 390 | 102,647 | 1 |
| 391 | 52,647 | 1 |
| 392 | 290,847 | 1 |
| 393 | 27,947 | 1 |
| 394 | 17157 | 1 |
| 395 | 23,357 | 1 |
| 396 | 26,957 | 1 |
| 397 | 6,367 | 1 |
| 398 | 18,867 | 1 |
| 399 | 19,867 | 1 |
| 400 | 0.85:67 | 1 |
| 401 | 14,277 | 1 |
| 402 | 137,277 | 1 |
| 403 | 11,377 | 1 |
| 404 | 6,377 | 1 |
| 405 | 5,477 | 1 |
| 406 | 5877 | 1 |
| 407 | 9,187 | 1 |
| 408 | 64,387 | 1 |
| 409 | 2,487 | 1 |
| 410 | 5,587 | 1 |
| 411 | 9,297 | 1 |
| 412 | 76,397 | 1 |
| 413 | 164,497 | 1 |
| 414 | 72,597 | 1 |
| 415 | 49,697 | 1 |
| 416 | 3997 | 2 |
| 417 | 11,108 | 1 |
| 418 | 3,508 | 1 |
| 419 | 115,608 | 1 |
| 420 | 8,708 | 1 |
| 421 | 82,018 | 1 |
| 422 | 5,118 | 1 |
| 423 | 169,518 | 1 |
| 424 | 20618 | 1 |
| 425 | 8718 | 1 |
| 426 | 111,818 | 1 |
| 427 | 40,028 | 1 |
| 428 | 173,028 | 1 |
| 429 | 17,028 | 1 |
| 430 | 8,528 | 1 |
| 431 | 28,628 | 1 |
| 432 | 9,138 | 1 |
| 433 | 33,238 | 1 |
| 434 | 11,638 | 1 |
| 435 | 242,738 | 1 |
| 436 | 6738 | 1 |
| 437 | 9838 | 1 |
| 438 | 4048 | 1 |
| 439 | 47,148 | 1 |
| 440 | 48248 | 1 |
| 441 | 30,348 | 1 |
| 442 | 7,648 | 1 |
| 443 | 44,948 | 1 |
| 444 | 9948 | 1 |
| 445 | 7/58 | 2 |
| 446 | 142,158 | 1 |
| 447 | the1158 | 1 |
| 448 | 6158 | 1 |
| 449 | 8158 | 1 |
| 450 | 32,258 | 2 |
| 451 | 12,358 | 1 |
| 452 | 623,358 | 1 |
| 453 | 122,458 | 1 |
| 454 | 97,458 | 1 |
| 455 | 5458 | 1 |
| 456 | 94,558 | 1 |
| 457 | 6558 | 3 |
| 458 | 69,958 | 2 |
| 459 | 374,068 | 1 |
| 460 | 12,168 | 1 |
| 461 | 240,268 | 1 |
| 462 | 2,568 | 1 |
| 463 | 23,668 | 1 |
| 464 | 163,668 | 1 |
| 465 | 3,678,868 | 1 |
| 466 | 5078 | 1 |
| 467 | 20,478 | 1 |
| 468 | 52,778 | 1 |
| 469 | 6,778 | 1 |
| 470 | 41,088 | 1 |
| 471 | 9388 | 1 |
| 472 | 29,488 | 1 |
| 473 | 81788 | 1 |
| 474 | 17,888 | 1 |
| 475 | 8,988 | 1 |
| 476 | 8988 | 1 |
| 477 | 4,498 | 1 |
| 478 | 86,598 | 1 |
| 479 | 2,698 | 1 |
| 480 | 3,798 | 1 |
| 481 | 156,798 | 1 |
| 482 | 4998 | 1 |
| 483 | 58,009 | 1 |
| 484 | 171/309 | 1 |
| 485 | 415,409 | 1 |
| 486 | 6409 | 1 |
| 487 | 4,609 | 1 |
| 488 | 226,709 | 1 |
| 489 | 8,909 | 1 |
| 490 | 8519 | 1 |
| 491 | 9519 | 1 |
| 492 | 7,619 | 1 |
| 493 | 10,819 | 1 |
| 494 | 32,919 | 1 |
| 495 | 17029 | 1 |
| 496 | 10,129 | 1 |
| 497 | 37,229 | 1 |
| 498 | 33,429 | 1 |
| 499 | 152,729 | 1 |
| 500 | 2,660,929 | 1 |
| 501 | 27,039 | 1 |
| 502 | 30,139 | 1 |
| 503 | 5,239 | 1 |
| 504 | 35,239 | 1 |
| 505 | 22.239 | 1 |
| 506 | 38,439 | 1 |
| 507 | 167,839 | 1 |
| 508 | 6549 | 1 |
| 509 | 81,649 | 1 |
| 510 | 4649 | 1 |
| 511 | n=6259 | 1 |
| 512 | 4,459 | 1 |
| 513 | 5659 | 1 |
| 514 | 4859 | 1 |
| 515 | 13,169 | 1 |
| 516 | 13269 | 1 |
| 517 | 11,369 | 1 |
| 518 | 10,469 | 1 |
| 519 | 33,669 | 1 |
| 520 | 36,869 | 1 |
| 521 | 98,869 | 1 |
| 522 | 21,379 | 1 |
| 523 | 20,479 | 1 |
| 524 | 41,479 | 1 |
| 525 | 24,979 | 1 |
| 526 | 6289 | 1 |
| 527 | 16,489 | 1 |
| 528 | 36,489 | 1 |
| 529 | 7489 | 1 |
| 530 | 2589 | 7 |
| 531 | 5,889 | 1 |
| 532 | 2989 | 4 |
| 533 | 9199 | 1 |
| 534 | 7499 | 1 |
| 535 | 20,599 | 1 |
| 536 | 48,599 | 1 |
| 537 | 49,599 | 1 |
| 538 | 13,699 | 1 |
| 539 | 221,799 | 1 |
| 540 | 5799 | 3 |
| 541 | 5899 | 1 |
| 542 | nssa | 1 |
| 543 | non-ranibizumab | 1 |
| 544 | 198mb | 1 |
| 545 | dysmennorheic | 1 |
| 546 | nitroimidazole-allergic | 1 |
| 547 | hn-allergic | 1 |
| 548 | cat-allergic | 3 |
| 549 | acalculic | 1 |
| 550 | -ischemic | 1 |
| 551 | diabetic-hypercholesterolemic | 4 |
| 552 | 'uremic | 1 |
| 553 | hospitalized-manic | 1 |
| 554 | lupic | 2 |
| 555 | homokaryotypic | 1 |
| 556 | chagasic | 73 |
| 557 | di-abetic | 1 |
| 558 | diabetic | 14,345 |
| 559 | 'diabetic | 11 |
| 560 | life-diabetic | 2 |
| 561 | cysticercotic | 1 |
| 562 | amyloidotic | 15 |
| 563 | cirrhotic | 605 |
| 564 | scoliotic | 17 |
| 565 | post-ec-tcpc | 1 |
| 566 | vvir-paced | 1 |
| 567 | pheochromocytoma-induced | 2 |
| 568 | bortezomib-induced | 13 |
| 569 | thalidomide/bortezomib-induced | 1 |
| 570 | hmg-coa-reductase-induced | 1 |
| 571 | dcf-induced | 1 |
| 572 | carboplatin/paclitaxel-induced | 1 |
| 573 | nsaids-induced | 4 |
| 574 | ket-induced | 3 |
| 575 | rhcmv-induced | 1 |
| 576 | avv-tenos-transduced | 1 |
| 577 | ultrasonographic-guided | 2 |
| 578 | white-coded | 1 |
| 579 | half-blooded | 1 |
| 580 | hfd-fed | 34 |
| 581 | fructose-fed | 43 |
| 582 | flat-arched | 1 |
| 583 | age-and-sex-matched | 1 |
| 584 | prematched | 1 |
| 585 | ex-smokers/never-smoked | 1 |
| 586 | chemotherapy-evoked | 1 |
| 587 | mustt-enrolled | 1 |
| 588 | op-poisoned | 2 |
| 589 | non-entered | 3 |
| 590 | telemetry-monitored | 1 |
| 591 | acne-scarred | 1 |
| 592 | doctor-referred | 1 |
| 593 | leukapheresed | 1 |
| 594 | adalimumab-randomised | 3 |
| 595 | splectomised | 1 |
| 596 | non-splectomised | 1 |
| 597 | pcr-diagnosed | 2 |
| 598 | tdf-exposed | 1 |
| 599 | vigabatrin-exposed | 2 |
| 600 | vascular-complicated | 2 |
| 601 | aspirin-allocated | 1 |
| 602 | non-ketamine-sedated | 1 |
| 603 | well-sedated | 1 |
| 604 | oversedated | 1 |
| 605 | i300-treated | 1 |
| 606 | a10-treated | 1 |
| 607 | i150/a10-treated | 1 |
| 608 | hidac-3-treated | 1 |
| 609 | hmpl-004-treated | 2 |
| 610 | a5-treated | 1 |
| 611 | i300/a5-treated | 1 |
| 612 | i150/a5-treated | 1 |
| 613 | cisca-treated | 1 |
| 614 | enoxaparin/vka-treated | 1 |
| 615 | mdma-treated | 6 |
| 616 | htupa-treated | 1 |
| 617 | za-treated | 1 |
| 618 | intetumumab-treated | 1 |
| 619 | palbociclib-treated | 1 |
| 620 | afatinib-treated | 3 |
| 621 | cabozantinib-treated | 1 |
| 622 | ibrutinib-treated | 1 |
| 623 | mvac-treated | 1 |
| 624 | hec-treated | 1 |
| 625 | cbz-erc-treated | 1 |
| 626 | tocilizumab-sc-treated | 1 |
| 627 | ambd-treated | 1 |
| 628 | lvd-treated | 1 |
| 629 | cae-treated | 1 |
| 630 | nitroprusside-treated | 2 |
| 631 | taspoglutide-treated | 1 |
| 632 | itraconazole-treated | 3 |
| 633 | sulconazole-treated | 2 |
| 634 | mericitabine-treated | 1 |
| 635 | quifenadine-treated | 1 |
| 636 | thienoypridine-treated | 1 |
| 637 | diphenhydramine-treated | 1 |
| 638 | dacarbazine-treated | 1 |
| 639 | troglitazone-treated | 7 |
| 640 | tolciclate-treated | 1 |
| 641 | m-csf-treated | 1 |
| 642 | myrrh-treated | 2 |
| 643 | q4-wk-treated | 1 |
| 644 | perampanel-treated | 1 |
| 645 | piribedil-treated | 1 |
| 646 | atovaquone-proguanil-treated | 1 |
| 647 | rioprostil-treated | 1 |
| 648 | cefprozil-treated | 2 |
| 649 | pcnl-treated | 1 |
| 650 | esmolol-treated | 6 |
| 651 | srl-treated | 5 |
| 652 | aztreonam-treated | 2 |
| 653 | ertapenem-treated | 1 |
| 654 | romiplostim-treated | 10 |
| 655 | tpm-treated | 3 |
| 656 | topotecan-treated | 1 |
| 657 | carrageenan-treated | 3 |
| 658 | ximelagatran-treated | 1 |
| 659 | sumatriptan-treated | 4 |
| 660 | zolmitriptan-treated | 1 |
| 661 | almotriptan-treated | 1 |
| 662 | naproxen-treated | 7 |
| 663 | fidaxomicin-treated | 3 |
| 664 | micafungin-treated | 1 |
| 665 | caspofungin-treated | 4 |
| 666 | oxaliplatin-treated | 4 |
| 667 | imipenem/cilastatin-treated | 1 |
| 668 | darbepoetin-treated | 2 |
| 669 | gbp-treated | 1 |
| 670 | hep-treated | 1 |
| 671 | dhp-treated | 1 |
| 672 | giop-treated | 1 |
| 673 | pi/r-treated | 1 |
| 674 | detemir-treated | 1 |
| 675 | lopinavir/ritonavir-treated | 1 |
| 676 | darunavir/ritonavir-treated | 1 |
| 677 | boceprevir-treated | 1 |
| 678 | adefovir-treated | 1 |
| 679 | daclatasvir-treated | 1 |
| 680 | simeprevir/pr-treated | 2 |
| 681 | savr-treated | 2 |
| 682 | des-treated | 7 |
| 683 | c-ses-treated | 1 |
| 684 | cnis-treated | 1 |
| 685 | fibrinolysis-treated | 1 |
| 686 | fibrocaps-treated | 2 |
| 687 | temsirolimus-treated | 1 |
| 688 | sipuleucel-t-treated | 2 |
| 689 | ldt-treated | 1 |
| 690 | paft-treated | 1 |
| 691 | rilonacept-treated | 2 |
| 692 | icu-treated | 1 |
| 693 | nfv-treated | 1 |
| 694 | tocilizumab-iv-treated | 1 |
| 695 | smv-treated | 2 |
| 696 | stomaphyx-treated | 1 |
| 697 | maximally-treated | 1 |
| 698 | radiosurgery-treated | 1 |
| 699 | tcz-treated | 1 |
| 700 | sca3-associated | 2 |
| 701 | capcaa-associated | 1 |
| 702 | p2xr-mediated | 1 |
| 703 | cldn16-related | 1 |
| 704 | non-bleb-related | 1 |
| 705 | thalidomide-related | 1 |
| 706 | emergency-related | 3 |
| 707 | ischemic-dilated | 1 |
| 708 | biomarker-evaluated | 1 |
| 709 | heat-affected | 3 |
| 710 | gonorrhea-infected | 1 |
| 711 | worm-infected | 1 |
| 712 | helicobacter-infected | 2 |
| 713 | chronically-infected | 2 |
| 714 | hiv-/hcv-coinfected | 1 |
| 715 | nafld-suspected | 1 |
| 716 | mg-depleted | 3 |
| 717 | tcp-supplemented | 1 |
| 718 | dhea-substituted | 1 |
| 719 | simulators-standardized | 1 |
| 720 | ami-hospitalized | 1 |
| 721 | non-immunocompromized | 2 |
| 722 | tympanostomized | 1 |
| 723 | 16-24-year-old | 1 |
| 724 | 17-18-year-old | 1 |
| 725 | 16-to-78-year-old | 1 |
| 726 | earth-bound | 1 |
| 727 | nausea-free | 1 |
| 728 | gde-free | 1 |
| 729 | adhesion-free | 1 |
| 730 | nonstroke | 14 |
| 731 | cardiac-stable | 1 |
| 732 | alda-eligible | 1 |
| 733 | solvd-eligible | 2 |
| 734 | rely-able-eligible | 1 |
| 735 | merit-hf-eligible | 1 |
| 736 | cabg-eligible | 1 |
| 737 | insulin-eligible | 2 |
| 738 | giop-eligible | 1 |
| 739 | rales-eligible | 1 |
| 740 | thrombolysis-eligible | 3 |
| 741 | randomised/eligible | 1 |
| 742 | low-mobile | 4 |
| 743 | mustt/madit-type | 1 |
| 744 | ruxolitinib-naive | 1 |
| 745 | atnf-naive | 1 |
| 746 | lfn-naive | 1 |
| 747 | erythropoietin-naive | 1 |
| 748 | low-impulsive | 2 |
| 749 | tamoxifen-responsive | 1 |
| 750 | cfa-negative | 1 |
| 751 | bacteria-negative | 2 |
| 752 | vhl-inactive | 1 |
| 753 | ca125-positive | 1 |
| 754 | gada-positive | 1 |
| 755 | tgab-positive | 5 |
| 756 | amyloid-positive | 5 |
| 757 | dipstick-positive | 8 |
| 758 | toxo-positive | 1 |
| 759 | auto-antibody-positive | 1 |
| 760 | cgrp-immunopositive | 1 |
| 761 | imatinib-naïve | 1 |
| 762 | state-of | 1 |
| 763 | obliging | 1 |
| 764 | neoplasia-bearing | 1 |
| 765 | cd16+/ido+-expressing | 1 |
| 766 | cytokine-expressing | 1 |
| 767 | alt-elevating | 1 |
| 768 | invasion-supporting | 1 |
| 769 | long-surviving | 3 |
| 770 | pampc-carrying | 1 |
| 771 | nc-cah | 1 |
| 772 | arb/acei | 1 |
| 773 | inoperable/high-risk | 2 |
| 774 | non-msk | 1 |
| 775 | health.gonococcal | 1 |
| 776 | latero-frontal | 1 |
| 777 | corneoconjunctival | 1 |
| 778 | ctc/ml | 1 |
| 779 | euro-canadian | 1 |
| 780 | snake-bitten | 1 |
| 781 | receptor-in | 1 |
| 782 | cryoblation | 1 |
| 783 | high-utilization | 1 |
| 784 | nonburn | 3 |
| 785 | rcts-after | 1 |
| 786 | good-mr | 1 |
| 787 | fractures.twenty-four | 1 |
| 788 | antecedes | 1 |
| 789 | post-is | 1 |
| 790 | non-appendicitis | 1 |
| 791 | good-ps | 1 |
| 792 | allogeneic-hct | 4 |
| 793 | non-transplant | 19 |
| 794 | obliterant | 1 |
| 795 | ptps-deficient | 3 |
| 796 | adherent/non-adherent | 1 |
| 797 | infliximab-to-abatacept | 2 |
| 798 | years-mostly | 1 |
| 799 | fluorouracil-refractory | 1 |
| 800 | lamivudin-refractory | 1 |
| 801 | lower-priority | 1 |